Risk of Asthma in Infants With Atopic Dermatitis
NCT00459576 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2013-04-17
Summary
Infants will be enrolled in this study if they have never been diagnosed with asthma or wheezing and have been diagnosed with atopic dermatitis or eczema. Infants with some types of skin rashes are at high risk for developing asthma by 6 years of age. The purpose of this study is to determine whether we can identify infants who will develop asthma.
Conditions
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
Indiana University School of Medicine
lead OTHER
Principal Investigators
-
Robert S Tepper, MD, PhD · Indiana University
Eligibility
- Min Age
- 2 Months
- Max Age
- 7 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-05-31
- Primary Completion
- 2012-01-31
- Completion
- 2012-12-31
Countries
- United States
Study Locations
More Related Trials
-
Developing a Childhood Asthma Risk Passive Digital Marker
NCT05826561 ·Status: TERMINATED ·Phase: NA
-
A Study of 2 Doses of MAP0010 in Asthmatic Children
NCT00697697 ·Status: TERMINATED ·Phase: PHASE3
-
Antibiotics in Infancy--Risk Factor for Childhood Asthma
NCT00037726 ·Status: COMPLETED
-
Exhaled Nitric Oxide and Airway Caliber in Children With Asthma
NCT01645397 ·Status: COMPLETED
-
The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children
NCT02743663 ·Status: COMPLETED
-
Environmental Exposures, Genetics, and Exhaled Nitric Oxide in Pediatric Asthma
NCT00395096 ·Status: COMPLETED
-
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
NCT00367016 ·Status: COMPLETED ·Phase: PHASE4
-
A Long-Term Examination of Asthma From Childhood Through Adolescence
NCT00541255 ·Status: COMPLETED
-
Individualized Therapy For Asthma in Toddlers
NCT01606306 ·Status: COMPLETED ·Phase: PHASE3
-
Genetic Studies in Difficult to Treat Asthma: TENOR
NCT00091767 ·Status: COMPLETED
-
Preventing Asthma in High Risk Kids
NCT02570984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Montelukast With Status Asthmaticus, Ages 2-5
NCT00491790 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Children's Respiratory and Environmental Workgroup
NCT03213184 ·Status: COMPLETED
-
Longitudinal Study of Asthma From Birth to Adulthood
NCT00005475 ·Status: COMPLETED
-
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
NCT02502890 ·Status: COMPLETED
-
Montelukast With Status Asthmaticus, Ages 6-18
NCT00494572 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
NCT06191315 ·Status: RECRUITING ·Phase: PHASE3
-
Markers of Airway Inflammation in BAL Fluid From Children With Asthma
NCT00838552 ·Status: COMPLETED
-
Allergy Immunotherapy for the Reduction of Asthma
NCT01028560 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of MAP0010 in Asthmatic Children and Adolescents
NCT00697801 ·Status: COMPLETED ·Phase: PHASE2
-
Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma
NCT02360072 ·Status: COMPLETED
-
Epidemiology of Pediatric Asthma Hospitalization
NCT00005445 ·Status: COMPLETED
-
Prevention of Early Asthma in Kids (PEAK)
NCT00272441 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Personalized Medicine for Pediatric Asthma
NCT01681732 ·Status: COMPLETED ·Phase: NA
-
Genetic Risk Factors for Severe Asthma
NCT00090740 ·Status: COMPLETED